Hinge Health - Class A opened lower at $114.44, compared with its previous close of $116.90. In the last trading session, the stock traded between $112.54 and $115.80. It showed a downward intraday trend.
return calculator
Time Period
An investment of $100 made 2 years ago in Hinge Health - Class A is now worth
$ 301.49
giving a profit of
$ 201.49 (201.49%)
invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 14 Analysts
Buy
92.86%
Hold
7.14%
Sell
0%
Markets Today
Today's Change
$-3.66 (-3.13%)
Day High
$115.80
Day Low
$112.54
Day Open
$114.44
Prev Close
$116.90
Volume
4,90,789
1W Return
2.99%
1M Return
18.86%
3M Return
52.80%
6M Return
157.42%
1Y Return
128.31%
Fundamentals
Market Cap ($ Mn)
7,074
PE Ratio
28.83
PB Ratio
20.35
PEG Ratio
-
ROE
-
ROCE
-129.00%
EPS (TTM)
-
Investment Returns
1 Week
2.99%
1 Month
18.86%
3 Months
52.80%
6 Months
157.42%
9 Months
212.64%
Financials
Quarterly
All values in $ Mn
123.8
Mar 25
139.1
Jun 25
154.2
Sep 25
170.7
Dec 25
182.3
Mar 26
212.8
Jun 26
Updates
7Oct
Hinge Health sees hardware deals ahead in digital health push
Hinge Health is pursuing hardware acquisitions. Strategy focuses on integrating devices with software. Move aims to enhance digital health platform capabilities.
22 days ago
5Oct
Hinge Health to report Q3 2026 financial results on November 2
Hinge Health will announce Q3 2026 results on November 2, 2026. Earnings call scheduled for 1:30 p.m. Pacific Time. Webcast available via Investor Relations website with subsequent replay.
25 days ago
30Jul
Hinge Health study shows 57% lower ER visit odds for seniors
Hinge Health announced a study showing its fall prevention program reduced falls by 37% and ER visits by 57% among adults aged 65+. The trial of 687 participants showed significant gains in physical function, offering a scalable solution to reduce costs and improve outcomes for Medicare Advantage plans.
3mo ago
21Jul
Canaccord raises Hinge Health target to $100
Canaccord Genuity analyst Richard Close maintained a Buy rating on Hinge Health (NYSE: HNGE) and raised the price target from $76 to $100. The revision reflects a stronger outlook for the digital health company's growth.
3mo ago
13Jul
Barclays maintains Overweight on Hinge Health, raises target to $97
Barclays analyst Saket Kalia maintained an Overweight rating on Hinge Health (NYSE: HNGE) and raised the price target to $97 from $70, reflecting increased confidence in the company's growth prospects.
3mo ago
7Jul
Hinge Health to report Q2 2026 results on August 4
Hinge Health, Inc. will announce its Q2 2026 financial results on August 4, 2026, followed by an earnings call. The company focuses on scaling healthcare delivery through AI and wearable technology.
